HPLC法同时测定养心草中没食子酸、槲皮素和山萘酚的含量

建立了高效液相色谱法同时测定养心草中没食子酸、槲皮素和山萘酚的含量。采用Hypersil C18色谱柱（4.6mm×200mm,5μm）,流动相为甲醇（A）-0.2%磷酸水溶液（B）,梯度洗脱,流速1.0mL/min;柱温25℃;检测波长260nm。在选定色谱条件下没食子酸、槲皮素和山萘酚线性关系良好;没食子酸、槲皮素和山萘酚加标回收率分别为98.37%、99.61%、97.81%,RSD分别为2.32%、2.15%、2.20%。方法简便快速,结果准确可靠,可用于控制中药养心草的质量。     

3D-QSAR Studies on 4-([1,2,4]Triazolo[1,5-α]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole Analogues as Potent Inhibitors of Transforming Growth Factor-β Type Ⅰ Receptor Kinase

The transforming growth factor-β(TGF-β) plays a crucial role in the beginning and progression of fibrosis in various organ systems such as lung, heart, liver and kidney. TGF-β type I receptor kinase(activin receptor-like kinase 5, ALK5) inhibitors might have potential activity for the treatment of relevant diseases. In this paper, the three-dimensional quantitative structure-activity relationship(3 D-QSAR) including comparative molecular field analysis(Co MFA) and comparative molecular similarity indices analysis(Co MSIA) were used to analyze the structural requirements based on a dataset of 123 4-([1,2,4]Triazolo[1,5-α]pyridine-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole analogues which acted as ALK5 inhibitors. The obtained Co MFA model(q~2 = 0.652, r~2 = 0.876, r~2 pred = 0.845) and Co MSIA model(q~2 = 0.648, r~2 = 0.884, r~2 pred = 0.853) were robust and satisfactory. The predictive ability of the derived models was validated using a test set of 28 compounds. Additionally, potentially important structural features required to enhance activity were also elucidated by the contour maps derived from Co MFA and Co MSIA models. The results will be helpful to guide drug design strategies aimed at obtaining potent and selective ALK5 inhibitors.